Mechanistic studies of Sansalvamide A-amide: An allosteric modulator of Hsp90

Regulation of Signaling Protein Function and Trafficking by the hsp90/hsp70-Based Chaperone Machinery

Pratt, W. B., & Toft, D. O. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800201 · Cited by 1,478 · see citing works

A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors

Kamal, A., Thao, L., Sensintaffar, J., Zhang, L., Boehm, M. F., Fritz, L. C., & Burrows, F. J. (2003) · Nature · doi:10.1038/nature01913 · Cited by 1,380 · see citing works

Role of the Heat Shock Response and Molecular Chaperones in Oncogenesis and Cell Death

Jolly, C. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.19.1564 · Cited by 1,049 · see citing works

Hsp90 inhibitors as novel cancer chemotherapeutic agents

Neckers, L. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02316-x · Cited by 677 · see citing works

Novobiocin and Related Coumarins and Depletion of Heat Shock Protein 90-Dependent Signaling Proteins

Marcu, M. G., Schulte, T. W., & Neckers, L. Μ. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.3.242 · Cited by 405 · see citing works

Heat shock protein 90

Neckers, L., & Ivy, S. P. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200311000-00003 · Cited by 400 · see citing works

Sensitivity of Mature ErbB2 to Geldanamycin Is Conferred by Its Kinase Domain and Is Mediated by the Chaperone Protein Hsp90

Xu, W., Mimnaugh, E. G., Rosser, M. F. N., Nicchitta, C. V., Marcu, M. G., Yarden, Y., & Neckers, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m006864200 · Cited by 350 · see citing works

Two mammalian heat shock proteins, HSP90 and HSP100, are actin-binding proteins.

Koyasu, S., Nishida, E., Kadowaki, T., Matsuzaki, F., Iida, K., Harada, F., Kasuga, M., Sakai, H., & Yahara, I. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.21.8054 · Cited by 329 · see citing works

Novobiocin and Additional Inhibitors of the Hsp90 C-Terminal Nucleotide- binding Pocket

Donnelly, A. C., & Blagg, B. S. J. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708786242895 · Cited by 314 · see citing works

Role of the Myosin Assembly Protein UNC-45 as a Molecular Chaperone for Myosin

Barral, J. M., Hutagalung, A. H., Brinker, A., Hartl, F. U., & Epstein, H. F. (2002) · Science · doi:10.1126/science.1066648 · Cited by 252 · see citing works

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Metastatic Melanoma

Solit, D. B., Osman, I., Polsky, D., Panageas, K. S., DAUD, A. I., Goydos, J. S., Teitcher, J. B., Wolchok, J. D., Germino, F. J., Krown, S. E., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-1002 · Cited by 188 · see citing works

A Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients with Hormone-Refractory Metastatic Prostate Cancer

Heath, E. I., Hillman, D. W., Vaishampayan, U. N., Sheng, S., Sarkar, F. H., Harper, F. W. K., Gaskins, M., Pitot, H. C., Tan, W. W., Ivy, S. P., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0221 · Cited by 186 · see citing works

Mechanism of Dimer Formation of the 90‐kDa Heat‐Shock Protein

Nemoto, T., Ohara‐Nemoto, Y., Ota, M., Takagi, T., & Yokoyama, K. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.001_1.x · Cited by 176 · see citing works

In vivo antitumor efficacy of 17-DMAG (17-dimethylaminoethylamino-17-demethoxygeldanamycin hydrochloride), a water-soluble geldanamycin derivative

Hollingshead, M. G., Alley, M. C., Burger, A. M., Borgel, S. D., Pacula-Cox, C. M., Fiebig, H., & Sausville, E. A. (2005) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-004-0939-2 · Cited by 151 · see citing works

Sansalvamide: A new cytotoxic cyclic depsipeptide produced by a marine fungus of the genus Fusarium

Belofsky, G. N., Jensen, P. R., & Fenical, W. (1999) · Tetrahedron Letters · doi:10.1016/s0040-4039(99)00393-7 · Cited by 150 · see citing works

17AAG: low target binding affinity and potent cell activity--finding an explanation.

Chiosis, G., Huezo, H., Rosen, N. X., Mimnaugh, E. G., Whitesell, L. J., & Neckers, L. (2003) · PubMed · Cited by 149 · see citing works

Hsp90 restrains ErbB‐2/HER2 signalling by limiting heterodimer formation

Citri, A., Gan, J., Mosesson, Y., Vereb, G., Szöllõsi, J., & Yarden, Y. (2004) · EMBO Reports · doi:10.1038/sj.embor.7400300 · Cited by 139 · see citing works

17 AAG for HSP90 Inhibition in Cancer – From Bench to Bedside

Usmani, S. Z., Bona, R., & Li, Z. (2009) · Current Molecular Medicine · doi:10.2174/156652409788488757 · Cited by 119 · see citing works

HSP90 regulates cell survival via inositol hexakisphosphate kinase-2

Chakraborty, A., Koldobskiy, M. A., Sixt, K. M., Juluri, K. R., Mustafa, A. K., Snowman, A. M., van Rossum, D. B., Patterson, R. L., & Snyder, S. H. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711168105 · Cited by 118 · see citing works

Evidence that the 90-Kilodalton Heat Shock Protein is Associated with Tubulin-Containing Complexes in L Cell Cytosol and in Intact PtK Cells

Sánchez, E. R., Redmond, T., Scherrer, L. C., Bresnick, E. H., Welsh, M. J., & Pratt, W. B. (1988) · Molecular Endocrinology · doi:10.1210/mend-2-8-756 · Cited by 113 · see citing works

Mechanism of Inhibition of a Poxvirus Topoisomerase by the Marine Natural Product Sansalvamide A

Hwang, Y. S., Rowley, D. C., Rhodes, D., Gertsch, J., Fenical, W., & Bushman, F. D. (1999) · Molecular Pharmacology · doi:10.1124/mol.55.6.1049 · Cited by 108 · see citing works

The pleiotropic nature of symbiotic regulatory mutants: Bradyrhizobium japonicum nifA gene is involved in control of nif gene expression and formation of determinate symbiosis

Fischer, H., Álvarez-Morales, A., & Hennecke, H. (1986) · The EMBO Journal · doi:10.1002/j.1460-2075.1986.tb04342.x · Cited by 105 · see citing works

Inhibition of cancer invasion and metastasis by targeting the molecular chaperone heat-shock protein 90.

Koga, F., Kihara, K., & Neckers, L. (2009) · PubMed · Cited by 94 · see citing works

N-Methylsansalvamide A Peptide Analogues. Potent New Antitumor Agents

Liu, S., Gu, W., Lo, D. J., Ding, X.-Z., Ujiki, M. B., Adrian, T. E., Soff, G. A., & Silverman, R. B. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm048952t · Cited by 83 · see citing works

Monomer Arrangement in HSP90 Dimer as Determined by Decoration with N and C-Terminal Region Specific Antibodies

Maruya, M., Sameshima, M., Nemoto, T., & Yahara, I. (1999) · Journal of Molecular Biology · doi:10.1006/jmbi.1998.2349 · Cited by 78 · see citing works

N-Methylsansalvamide, a cytotoxic cyclic depsipeptide from a marine fungus of the genus Fusarium

Cueto, M., Jensen, P. R., & Fenical, W. (2000) · Phytochemistry · doi:10.1016/s0031-9422(00)00280-6 · Cited by 72 · see citing works

Hsp90 inhibitors cause G2/M arrest associated with the reduction of Cdc25C and Cdc2 in lung cancer cell lines

千住, 恵., Sueoka, N., Sato, A., Iwanaga, K., Sakao, Y., Tomimitsu, S., Tominaga, M., Irie, K., Hayashi, S., & Sueoka, E. (2005) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-005-0047-7 · Cited by 71 · see citing works

Comprehensive Study of Sansalvamide A Derivatives and their Structure–Activity Relationships against Drug-Resistant Colon Cancer Cell Lines

Otrubova, K., Lushington, G. H., VanderVelde, D. G., McGuire, K. L., & McAlpine, S. R. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm070731a · Cited by 64 · see citing works

Unliganded and hormone-bound glucocorticoid receptors interact with distinct hydrophobic sites in the Hsp90 C-terminal domain

Fang, L., Ricketson, D., Getubig, L., & Darimont, B. D. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609163103 · Cited by 61 · see citing works

The Platelet-derived Growth Factor Receptor α Is Destabilized by Geldanamycins in Cancer Cells

Matei, D. E., Satpathy, M., Cao, L., Lai, Y.-C., Nakshatri, H., & Donner, D. B. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607012200 · Cited by 56 · see citing works

The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target

Barginear, M. F., Poznak, C. H. V., Rosen, N. X., Modi, S., Hudis, C. A., & Budman, D. R. (2008) · Current Cancer Drug Targets · doi:10.2174/156800908785699379 · Cited by 49 · see citing works

Heat shock protein HSP90 and its association with the cytoskeleton: a morphological study

Fostinis, Y., Theodoropoulos, P. A., Gravanis, A., & Stournaras, C. (1992) · Biochemistry and Cell Biology · doi:10.1139/o92-118 · Cited by 45 · see citing works

A comprehensive study of Sansalvamide A derivatives: The structure–activity relationships of 78 derivatives in two pancreatic cancer cell lines

Pan, P., Vasko, R. C., Lapera, S. A., Johnson, V. A., Sellers, R. P., Lin, C.-C., Pan, C., Davis, M. R., Ardi, V. C., & McAlpine, S. R. (2009) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2009.07.017 · Cited by 44 · see citing works

A novel peptide sansalvamide analogue inhibits pancreatic cancer cell growth through G0/G1 cell-cycle arrest

Ujiki, M. B., Milam, B., Ding, X.-Z., Roginsky, A. B., Salabat, M. R., Talamonti, M., Bell, R. H., Gu, W., Silverman, R. B., & Adrian, T. E. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.131 · Cited by 42 · see citing works

Involvement of calcium in the differential induction of heat shock protein 70 by heat shock protein 90 inhibitors, geldanamycin and radicicol, in human non-small cell lung cancer H460 cells

Chang, Y., Lee, L.-C., Sun, F., Chao, C., Fu, H., & Lai, Y. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20623 · Cited by 39 · see citing works

Synthesis and novel structure–activity relationships of potent sansalvamide A derivatives

Otrubova, K., Styers, T. J., Pan, P., Rodriguez, R. A., McGuire, K. L., & McAlpine, S. R. (2006) · Chemical Communications · doi:10.1039/b517434a · Cited by 26 · see citing works

IP6K2 is a client for HSP90 and a target for cancer therapeutics development

Shames, D. S., & Minna, J. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0711993105 · Cited by 23 · see citing works

Hsp90-containing multiprotein complexes in the eukaryotic microbe Achlya

Brunt, S. A., Perdew, G. H., Toft, D. O., & Silver, J. C. (1998) · Cell Stress and Chaperones · doi:10.1379/1466-1268(1998)003 · Cited by 14 · see citing works

Structure-activity of Sansalvamide A Derivatives and their Apoptotic Activity in the Pancreatic Cancer Cell Line PL-45

Rodríguez, R. A., Pan, P., Vasko, R. C., Pan, C., Disman, W. S., & McAlpine, S. R. (2008) · Redalyc (Universidad Autónoma del Estado de México) · Cited by 7 · see citing works

Marine Natural Products: A Source of Novel Anticancer Drugs

Khalifa, S. A. M., Elias, N., Farag, M. A., Chen, L., Saeed, A., Hegazy, M.-E. F., Moustafa, M. S., Abd El-Wahed, A., Al-Mousawi, S. M., Musharraf, S. G., et al. (2019) · Marine Drugs · doi:10.3390/md17090491 · Cited by 555 · see citing works

Hsp90: Structure and Function

Jackson, S. (2012) · Topics in current chemistry · doi:10.1007/128_2012_356 · Cited by 334 · see citing works

Conformational dynamics of the molecular chaperone Hsp90

Krukenberg, K. A., Street, T. O., Lavery, L. A., & Agard, D. A. (2011) · Quarterly Reviews of Biophysics · doi:10.1017/s0033583510000314 · Cited by 308 · see citing works

Current scenario of peptide-based drugs: the key roles of cationic antitumor and antiviral peptides

Mulder, K. C. L., de Lima, L. A., Miranda, V. D. J., Dias, S. C., & Franco, O. L. (2013) · Frontiers in Microbiology · doi:10.3389/fmicb.2013.00321 · Cited by 211 · see citing works

Cyclic Peptides as Drugs for Intracellular Targets: The Next Frontier in Peptide Therapeutic Development

Buckton, L. K., Rahimi, M. N., & McAlpine, S. R. (2020) · Chemistry - A European Journal · doi:10.1002/chem.201905385 · Cited by 194 · see citing works

Anticancer Inhibitors of Hsp90 Function

Garg, G., Khandelwal, A., & Blagg, B. S. J. (2016) · Advances in cancer research · doi:10.1016/bs.acr.2015.12.001 · Cited by 147 · see citing works

Progress in the Discovery and Development of Heat Shock Protein 90 (Hsp90) Inhibitors

Bhat, R., Tummalapalli, S. R., & Rotella, D. P. (2014) · Journal of Medicinal Chemistry · doi:10.1021/jm500823a · Cited by 130 · see citing works

Corresponding Functional Dynamics across the Hsp90 Chaperone Family: Insights from a Multiscale Analysis of MD Simulations

Morra, G., Potestio, R., Micheletti, C., & Colombo, G. (2012) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1002433 · Cited by 118 · see citing works

Targeting Hsp90 and its co-chaperones to treat Alzheimer’s disease

Blair, L. J., Sabbagh, J. J., & Dickey, C. (2014) · Expert opinion on therapeutic targets · doi:10.1517/14728222.2014.943185 · Cited by 113 · see citing works

Hsp70 Protein Complexes as Drug Targets

Assimon, V. A., Gillies, A. T., Rauch, J. N., & Gestwicki, J. E. (2012) · Current Pharmaceutical Design · doi:10.2174/138161213804143699 · Cited by 116 · see citing works

Specific Binding of Tetratricopeptide Repeat Proteins to Heat Shock Protein 70 (Hsp70) and Heat Shock Protein 90 (Hsp90) Is Regulated by Affinity and Phosphorylation

Assimon, V. A., Southworth, D. R., & Gestwicki, J. E. (2015) · Biochemistry · doi:10.1021/acs.biochem.5b00801 · Cited by 112 · see citing works

Natural Product Inspired N‐Terminal Hsp90 Inhibitors: From Bench to Bedside?

Khandelwal, A., Crowley, V. M., & Blagg, B. S. J. (2015) · Medicinal Research Reviews · doi:10.1002/med.21351 · Cited by 109 · see citing works

Therapeutic Properties and Biological Benefits of Marine-Derived Anticancer Peptides

Kang, H. K., Choi, M., Seo, C., & Park, Y. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19030919 · Cited by 97 · see citing works

Inhibitors and chemical probes for molecular chaperone networks

Gestwicki, J. E., & Shao, H. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm118.002813 · Cited by 97 · see citing works

Allosteric Modulators of HSP90 and HSP70: Dynamics Meets Function through Structure-Based Drug Design

Ferraro, M., D’Annessa, I., Moroni, E., Morra, G., Paladino, A., Rinaldi, S., Compostella, F., & Colombo, G. (2018) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.8b00825 · Cited by 90 · see citing works

Refining the Natural Product Repertoire in Entomopathogenic Bacteria

Tobias, N. J., Shi, Y., & Bode, H. B. (2018) · Trends in Microbiology · doi:10.1016/j.tim.2018.04.007 · Cited by 86 · see citing works

Comparing proteins by their internal dynamics: Exploring structure–function relationships beyond static structural alignments

Micheletti, C. (2012) · Physics of Life Reviews · doi:10.1016/j.plrev.2012.10.009 · Cited by 86 · see citing works

Design and synthesis of Hsp90 inhibitors: Exploring the SAR of Sansalvamide A derivatives

Sellers, R. P., Alexander, L. D., Johnson, V. A., Lin, C.-C., Savage, J. H., Corral, R., Moss, J. A., Slugocki, T. S., Singh, E. K., Davis, M. R., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.07.042 · Cited by 82 · see citing works

Natural heat shock protein 90 inhibitors in cancer and inflammation

Costa, T. E. M. M., Raghavendra, N. M., & Penido, C. (2020) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2020.112063 · Cited by 81 · see citing works

Cyclic Peptides for the Treatment of Cancers: A Review

Ramadhani, D., Maharani, R., Gazzali, A. M., & Muchtaridi, M. (2022) · Molecules · doi:10.3390/molecules27144428 · Cited by 80 · see citing works

Small molecule modulators of protein-protein interactions: selected case studies

Aeluri, M., Chamakuri, S., Dasari, B., Guduru, S. K. R., Jimmidi, R., Jogula, S., & Arya, P. (2014) · Chemical Reviews · doi:10.1021/cr4004049 · Cited by 79 · see citing works

Targeting HSP90 as a Novel Therapy for Cancer: Mechanistic Insights and Translational Relevance

Zhang, J., Li, H., Liu, Y., Zhao, K., Wei, S., Sugarman, E. T., Liu, L., & Zhang, G. (2022) · Cells · doi:10.3390/cells11182778 · Cited by 76 · see citing works

Synthesis of sansalvamide A peptidomimetics: triazole, oxazole, thiazole, and pseudoproline containing compounds

Davis, M. R., Singh, E. K., Wahyudi, H., Alexander, L. D., Kunicki, J. B., Nazarova, L. A., Fairweather, K. A., Giltrap, A. M., Jolliffe, K. A., & McAlpine, S. R. (2011) · Tetrahedron · doi:10.1016/j.tet.2011.11.089 · Cited by 76 · see citing works

Macrocycles That Inhibit the Binding between Heat Shock Protein 90 and TPR-Containing Proteins

Ardi, V. C., Alexander, L. D., Johnson, V. A., & McAlpine, S. R. (2011) · ACS Chemical Biology · doi:10.1021/cb200203m · Cited by 69 · see citing works

Insect‐Specific Production of New GameXPeptides in Photorhabdus luminescens TTO1, Widespread Natural Products in Entomopathogenic Bacteria

Nollmann, F. I., Dauth, C., Mulley, G., Kegler, C., Kaiser, M., Waterfield, N. R., & Bode, H. B. (2014) · ChemBioChem · doi:10.1002/cbic.201402603 · Cited by 69 · see citing works

The conserved arginine 380 of Hsp90 is not a catalytic residue, but stabilizes the closed conformation required for ATP hydrolysis

Cunningham, C. N., Southworth, D. R., Krukenberg, K. A., & Agard, D. A. (2012) · Protein Science · doi:10.1002/pro.2103 · Cited by 67 · see citing works

N-terminal and C-terminal modulation of Hsp90 produce dissimilar phenotypes

Wang, Y., & McAlpine, S. R. (2014) · Chemical Communications · doi:10.1039/c4cc07284g · Cited by 65 · see citing works

Development of Heat Shock Protein (Hsp90) Inhibitors To Combat Resistance to Tyrosine Kinase Inhibitors through Hsp90–Kinase Interactions

Wang, M., Shen, A., Zhang, C., Song, Z., Ai, J., Liu, H., Sun, L., Ding, J., Geng, M., & Zhang, A. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5b01106 · Cited by 62 · see citing works

Biologically active macromolecules: Extraction strategies, therapeutic potential and biomedical perspective

Bilal, M., & Iqbal, H. M. N. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.02.037 · Cited by 61 · see citing works

C-terminal modulators of heat shock protein of 90 kDa (HSP90): State of development and modes of action

Bickel, D., & Gohlke, H. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.115080 · Cited by 61 · see citing works

Alternative approaches to Hsp90 modulation for the treatment of cancer

Hall, J. A., Forsberg, L. K., & Blagg, B. (2014) · Future Medicinal Chemistry · doi:10.4155/fmc.14.89 · Cited by 50 · see citing works

The Right Tool for the Job: An Overview of Hsp90 Inhibitors

Koren, J., & Blagg, B. S. J. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-40204-4_9 · Cited by 51 · see citing works

A heat shock protein 90 inhibitor that modulates the immunophilins and regulates hormone receptors without inducing the heat shock response

McConnell, J. R., Alexander, L. A., & McAlpine, S. R. (2013) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2013.11.059 · Cited by 52 · see citing works

Pan- and isoform-specific inhibition of Hsp90: Design strategy and recent advances

Yu, J., Zhang, C., & Song, C. (2022) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2022.114516 · Cited by 51 · see citing works

Identification of Hsp90 Inhibitors with Anti-Plasmodium Activity

Posfai, D., Eubanks, A. L., Keim, A. I., Lu, K., Wang, G. Z., Hughes, P. F., Kato, N., Haystead, T., & Derbyshire, E. R. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01799-17 · Cited by 50 · see citing works

Chemically Accessible Hsp90 Inhibitor That Does Not Induce a Heat Shock Response

Koay, Y. C., McConnell, J. R., Wang, Y., Kim, S. J., Buckton, L. K., Mansour, F., & McAlpine, S. R. (2014) · ACS Medicinal Chemistry Letters · doi:10.1021/ml500114p · Cited by 48 · see citing works

Macrocyclic Inhibitors of Hsp90

Johnson, V. A., Singh, E. K., Nazarova, L. A., Alexander, L. D., & McAlpine, S. R. (2010) · Current Topics in Medicinal Chemistry · doi:10.2174/156802610792232088 · Cited by 46 · see citing works

Design, Synthesis, and Biological Activities of Vibsanin B Derivatives: A New Class of HSP90 C-Terminal Inhibitors

Shao, L., Su, J., Ye, B., Liu, J., Zuo, Z., Li, Y., Wang, Y., Xia, C., & Zhao, Q. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b01395 · Cited by 45 · see citing works

X-linked inhibitor of apoptosis protein (XIAP) is a client of heat shock protein 70 (Hsp70) and a biomarker of its inhibition

Cesa, L. C., Shao, H., Srinivasan, S. R., Tse, E., Jain, C., Zuiderweg, E. R. P., Southworth, D. R., Mapp, A. K., & Gestwicki, J. E. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.000634 · Cited by 44 · see citing works

Design, synthesis and pharmacological evaluation of 4,5-diarylisoxazols bearing amino acid residues within the 3-amido motif as potent heat shock protein 90 (Hsp90) inhibitors

Zhang, C., Wang, X., Liu, H., Zhang, M., Geng, M., Sun, L., Shen, A., & Zhang, A. (2016) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2016.09.043 · Cited by 39 · see citing works

Synthesis and evaluation of biotinylated sansalvamide A analogs and their modulation of Hsp90

Kunicki, J. B., Petersen, M. N., Alexander, L. D., Ardi, V. C., McConnell, J. R., & McAlpine, S. R. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.06.083 · Cited by 37 · see citing works

Consecutive isocyanide-based multicomponent reactions: synthesis of cyclic pentadepsipeptoids

Barreto, A. D. F. S., Vercillo, O. E., Wessjohann, L. A., & Andrade, C. K. Z. (2014) · Beilstein Journal of Organic Chemistry · doi:10.3762/bjoc.10.101 · Cited by 33 · see citing works

Exploring the Binding Site of C-Terminal Hsp90 Inhibitors

Sgobba, M., Forestiero, R., Degliesposti, G., & Rastelli, G. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci1001857 · Cited by 33 · see citing works

The first report of direct inhibitors that target the C-terminal MEEVD region on heat shock protein 90

Buckton, L. K., Wahyudi, H., & McAlpine, S. R. (2015) · Chemical Communications · doi:10.1039/c5cc03245h · Cited by 31 · see citing works

Natural compounds in the regulation of proteostatic pathways: An invincible artillery against stress, ageing, and diseases

Upadhyay, A. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.01.006 · Cited by 31 · see citing works

Inhibitors of the Plasmodium falciparum Hsp90 towards Selective Antimalarial Drug Design: The Past, Present and Future

Stofberg, M. L., Caillet, C., de Villiers, M., & Zininga, T. (2021) · Cells · doi:10.3390/cells10112849 · Cited by 31 · see citing works

A highly selective Hsp90 affinity chromatography resin with a cleavable linker

Hughes, P. F., Barrott, J. J., Carlson, D. A., Loiselle, D. R., Speer, B. L., Bodoor, K., Rund, L. A., & Haystead, T. (2012) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2012.03.043 · Cited by 31 · see citing works

Natural HSP90 inhibitors as a potential therapeutic intervention in treating cancers: A comprehensive review

Liew, H. Y., Tan, X. Y., Chan, H. H., Khaw, K. Y., & Ong, Y. S. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106260 · Cited by 29 · see citing works

Effectively Delivering a Unique Hsp90 Inhibitor Using Star Polymers

Kim, S. J., Ramsey, D. M., Boyer, C. A., Davis, T. P., & McAlpine, S. R. (2013) · ACS Medicinal Chemistry Letters · doi:10.1021/ml400082b · Cited by 28 · see citing works

Can be marine bioactive peptides (MBAs) lead the future of foodomics for human health?

Rauf, A., Khalil, A. A., Khan, M., Anwar, S., Alamri, A., Alqarni, A. M., Alghamdi, A., Alshammari, F., Rengasamy, K. R. R., & Wan, C. C. (2021) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2021.1910482 · Cited by 29 · see citing works

Microbial cancer therapeutics: A promising approach

Diwan, D., Cheng, L., Usmani, Z., Sharma, M., Holden, N. J., Willoughby, N. A., Sangwan, N. S., Baadhe, R. R., Liu, C., & Gupta, V. K. (2021) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2021.05.003 · Cited by 25 · see citing works

HSP90: Chaperone-me-not

Patki, J., & Pawar, S. (2013) · Pathology & Oncology Research · doi:10.1007/s12253-013-9675-4 · Cited by 24 · see citing works

Dnj1 Promotes Virulence in Cryptococcus neoformans by Maintaining Robust Endoplasmic Reticulum Homeostasis Under Temperature Stress

Horianopoulos, L. C., Lee, C. W. J., Hu, G., Caza, M., & Kronstad, J. W. (2021) · Frontiers in Microbiology · doi:10.3389/fmicb.2021.727039 · Cited by 22 · see citing works

Multivalent protein–protein interactions are pivotal regulators of eukaryotic Hsp70 complexes

Johnson, O. T., & Gestwicki, J. E. (2022) · Cell Stress and Chaperones · doi:10.1007/s12192-022-01281-1 · Cited by 23 · see citing works

Protein–protein inhibitor designed de novo to target the MEEVD region on the C-terminus of Hsp90 and block co-chaperone activity

Rahimi, M. N., & McAlpine, S. R. (2018) · Chemical Communications · doi:10.1039/c8cc07576j · Cited by 23 · see citing works

Untitled work

(2013) · Cited by 22 · see citing works

Heat Shock Protein 90 Inhibitors as Therapeutic Agents

Gomez-Monterrey, I. M., Sala, M., Musella, S., & Campiglia, P. (2012) · Recent Patents on Anti-Cancer Drug Discovery · doi:10.2174/157489212801820066 · Cited by 22 · see citing works

Targeting hsp90 family members: A strategy to improve cancer cell death

Calderón, P. B., Beck, R., & Glorieux, C. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.04.010 · Cited by 20 · see citing works

Hitting a Moving Target: How Does an N‐Methyl Group Impact Biological Activity?

Koay, Y. C., Richardson, N., Zaiter, S. S., Kho, J., Nguyen, S. Y., Tran, D. H., Lee, K. W., Buckton, L. K., & McAlpine, S. R. (2016) · ChemMedChem · doi:10.1002/cmdc.201500572 · Cited by 19 · see citing works

Amino Acids Bearing Aromatic or Heteroaromatic Substituents as a New Class of Ligands for the Lysosomal Sialic Acid Transporter Sialin

Dubois, L., Pietrancosta, N., Cabayé, A., Fanget, I., Debacker, C., Gilormini, P., Dansette, P. M., Dairou, J., Biot, C., Froissart, R., et al. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b02119 · Cited by 19 · see citing works

Combining an Hsp70 inhibitor with either an N- or C-terminal Hsp90 inhibitor produces mechanistically distinct phenotypes

Wang, Y., & McAlpine, S. R. (2015) · Organic & Biomolecular Chemistry · doi:10.1039/c5ob00147a · Cited by 18 · see citing works

A small molecule that preferentially binds the closed conformation of Hsp90

Alexander, L. D., Partridge, J. R., Agard, D. A., & McAlpine, S. R. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.096 · Cited by 17 · see citing works

First Structural View of a Peptide Interacting with the Nucleotide Binding Domain of Heat Shock Protein 90

Raman, S., Singh, M., Tatu, U. S., & Suguna, K. (2015) · Scientific Reports · doi:10.1038/srep17015 · Cited by 17 · see citing works

Predicting the unpredictable: Recent structure–activity studies on peptide-based macrocycles

Wahyudi, H., & McAlpine, S. R. (2015) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2015.04.009 · Cited by 16 · see citing works

An Hsp90 modulator that exhibits a unique mechanistic profile

Ramsey, D. M., McConnell, J. R., Alexander, L. D., Tanaka, K. W., Vera, C. M., & McAlpine, S. R. (2012) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2012.03.012 · Cited by 15 · see citing works

Beyond Folding: Expanding the Functional Landscape of Hsp90 Chaperone Machinery in Health and Disease

Singh, M. K., Ranbhise, J. S., Fu, M., Ju, S., Han, S., Yun, H. R., Choe, W., Kim, S. S., & Kang, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262110279 · Cited by 15 · see citing works

Potential C-terminal-domain inhibitors of heat shock protein 90 derived from a C-terminal peptide helix

Gavenonis, J., Jonas, N., & Kritzer, J. A. (2014) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2014.06.006 · Cited by 14 · see citing works

Integrated Biological Control Using a Mixture of Two Entomopathogenic Bacteria, Bacillus thuringiensis and Xenorhabdus hominickii, against Spodoptera exigua and Other Congeners

Hrithik, M. T. H., Park, Y., Park, H., & Kim, Y. (2022) · Insects · doi:10.3390/insects13100860 · Cited by 13 · see citing works

Hsp90 Co-chaperones as Drug Targets in Cancer: Current Perspectives

Edkins, A. L. (2016) · Topics in medicinal chemistry · doi:10.1007/7355_2015_99 · Cited by 13 · see citing works

Molecular Dynamics Study of Naturally Existing Cavity Couplings in Proteins

Barbany, M., Meyer, T., Faustino, I., D’Abramo, M., Morata, J., Orozco, M., & de la Cruz, X. (2015) · PLoS ONE · doi:10.1371/journal.pone.0119978 · Cited by 12 · see citing works

Blocking the heat shock response and depleting HSF-1 levels through heat shock protein 90 (hsp90) inhibition: a significant advance on current hsp90 chemotherapies

Koay, Y. C., McConnell, J. R., Wang, Y., & McAlpine, S. R. (2015) · RSC Advances · doi:10.1039/c5ra07056b · Cited by 11 · see citing works

Anti-cancer properties of Sansalvamide A, its derivatives, and analogs: an updated review

Chagaleti, B. K., Baby, K., Peña‐Corona, S. I., Leyva‐Gómez, G., Sindhoor, S. M., Naveen, N. R., Jose, J., Aldahish, A. A., Sharifi‐Rad, J., & Călina, D. C. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03129-0 · Cited by 11 · see citing works

Reinventing Hsp90 Inhibitors: Blocking C‐Terminal Binding Events to Hsp90 by Using Dimerized Inhibitors

Koay, Y. C., Wahyudi, H., & McAlpine, S. R. (2016) · Chemistry - A European Journal · doi:10.1002/chem.201603464 · Cited by 10 · see citing works

Crystal structure of a member of a novel family of dioxygenases (PF10014) reveals a conserved cupin fold and active site

Xu, Q., Grant, J. C., Chiu, H., Farr, C. L., Jaroszewski, L., Knuth, M. W., Miller, M. D., Lesley, S. A., Godzik, A., Elsliger, M., et al. (2013) · Proteins Structure Function and Bioinformatics · doi:10.1002/prot.24362 · Cited by 10 · see citing works

Exploring the structures and molecular mechanisms of bioactive compounds from marine foods for hyperuricemia prevention: a systematic review

Meng, W., Zhang, J., Hou, H., Yu, L., & Dong, P. (2025) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2025.2464700 · Cited by 9 · see citing works

Reptiles as Promising Sources of Medicinal Natural Products for Cancer Therapeutic Drugs

Park, S. Y., Choi, H., & Chung, J. W. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14040874 · Cited by 9 · see citing works

Mechanistic Studies of Sanguinamide B Derivatives: A Unique Inhibitor of Eukaryotic Ribosomes

Tantisantisom, W., Ramsey, D. M., & McAlpine, S. R. (2013) · Organic Letters · doi:10.1021/ol401749p · Cited by 7 · see citing works

Anticancer effect of herbal and marine products: A systematic review

Rahaman, M. M., Wilairatana, P., Bappi, M. H., Islam, T., Mia, M. N., Coutinho, H. D. M., Siyadatpanah, A., & Islam, M. T. (2023) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2023.102919 · Cited by 7 · see citing works

Dimerization of a heat shock protein 90 inhibitor enhances inhibitory activity

Wahyudi, H., Wang, Y., & McAlpine, S. R. (2013) · Organic & Biomolecular Chemistry · doi:10.1039/c3ob41722k · Cited by 7 · see citing works

A silicon-containing aryl/penta-1,4-dien-3-one/amine hybrid exhibits antiproliferative effects on breast cancer cells by targeting the HSP90 C-terminus without inducing heat-shock response

Liao, Y. A., Du, X.-Y., Wang, M., Zheng, C., Li, D., Chen, C., Li, R., & Shao, L. (2023) · RSC Medicinal Chemistry · doi:10.1039/d3md00431g · Cited by 6 · see citing works

Recent Advances in Macrocyclic Hsp90 Inhibitors

Ramsey, D. M., Kitson, R. R. A., Levin, J. I., Moody, C. J., & McAlpine, S. R. (2014) · Royal Society of Chemistry eBooks · doi:10.1039/9781782623113-00037 · Cited by 6 · see citing works

Structural Diversity using Hyp “Customizable Units”: Proof‐of‐Concept Synthesis of Sansalvamide‐Related Antitumoral Peptides

Cuevas, F., Saavedra, C. J., Romero‐Estudillo, I., Boto, A., Ordóñez, M., & Vergara, I. (2020) · European Journal of Organic Chemistry · doi:10.1002/ejoc.202001427 · Cited by 6 · see citing works

Targeting Protein Synthesis, Folding, and Degradation Pathways in Cancer

Pasqua, E., Wilding, B., Cheeseman, M. D., & Jones, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-409547-2.12395-9 · Cited by 6 · see citing works

Enniatin A Analogues as Novel Hsp90 Inhibitors that Modulate Triple-Negative Breast Cancer

Serwetnyk, M. A., Crowley, V. M., Brackett, C. M., Carter, T. R., Elahi, A., Kommalapati, V. K., Chadli, A., & Blagg, B. S. J. (2023) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.3c00423 · Cited by 5 · see citing works

Exploiting Cancer Dependence on Molecular Chaperones

Sharp, S. Y., Jones, K., & Workman, P. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-396521-9.00009-7 · Cited by 5 · see citing works

Targeting the C-Terminus of Hsp90 as a Cancer Therapy

McConnell, J. R., Wang, Y., & McAlpine, S. R. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_93 · Cited by 5 · see citing works

Using NMR to identify binding regions for N and C-terminal Hsp90 inhibitors using Hsp90 domains

McConnell, J. R., Dyson, H. J., & McAlpine, S. R. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00387e · Cited by 5 · see citing works

Heat Shock Protein 90 and Reproduction in Female Animals: Ovary, Oocyte and Early Embryo

Yang, Y., Chen, L., & Yang, C. (2019) · Heat shock proteins · doi:10.1007/978-3-030-23158-3_23 · Cited by 4 · see citing works

Synthesis of C3′‐Foused Aryl/Penta‐1,4‐Dien‐3‐One/Amine Hybrids as HSP90C‐Terminal Inhibitors

Zheng, C., Liao, Y. A., Wang, H., Yang, C., Li, D., & Shao, L. (2024) · Chemistry & Biodiversity · doi:10.1002/cbdv.202400870 · Cited by 3 · see citing works

Delivering bioactive cyclic peptides that target Hsp90 as prodrugs

Huo, Y., Buckton, L. K., Bennett, J. L., Smith, E. C., Byrne, F. L., Hoehn, K. L., Rahimi, M. N., & McAlpine, S. R. (2019) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2019.1580276 · Cited by 3 · see citing works

Evaluating Dual Hsp90 and Hsp70 Inhibition as a Cancer Therapy

Buckton, L. K., Wang, Y., McConnell, J. R., & McAlpine, S. R. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_96 · Cited by 3 · see citing works

Heat Shock Protein 90: From Molecular Chaperone Function to Therapeutic Targeting in Malignancies

Zhang, B., Zou, X., Zhou, J., Sun, Q., & Chen, D. (2026) · Advanced Science · doi:10.1002/advs.75895 · Cited by 2 · see citing works

Non-Pharmaceutical Interventions in Cancer Therapy

Tyagi, V., Tanwar, N., Kumar, N., Phogat, N., Kumar, P., & Kumar, V. (2024) · Current Cancer Therapy Reviews · doi:10.2174/0115733947268161240404084729 · Cited by 2 · see citing works

Allosteric Inhibitors of Hsp70: Drugging the Second Chaperone of Tumorigenesis

Srinivasan, S. R., Shao, H., Li, X., & Gestwicki, J. E. (2015) · Topics in medicinal chemistry · doi:10.1007/7355_2015_88 · Cited by 2 · see citing works

Enhanced virulence of Beauveria bassiana against Thrips tabaci by the addition of bacterial metabolites derived from Xenorhabdus hominickii

Khan, F., & Kim, Y. (2022) · Journal of Asia-Pacific Entomology · doi:10.1016/j.aspen.2022.101997 · Cited by 2 · see citing works

Small-Molecule Inhibitors of Protein–Protein Interactions as Therapeutics

Poluri, K. M., Gulati, K., Tripathi, D. K., & Nagar, N. (2023) · Springer eBooks · doi:10.1007/978-981-99-2423-3_7 · Cited by 1 · see citing works

Click Chemistry: The Triazole Ring as a Privileged Peptidomimetic Scaffold

Trabocchi, A., & Guarna, A. (2014) · doi:10.1002/9781118683033.ch5 · Cited by 1 · see citing works

Allosteric Modulators of Heat Shock Protein 90 (HSP90)

Koay, Y. C., & McAlpine, S. R. (2016) · Royal Society of Chemistry eBooks · doi:10.1039/9781782629276-00404

Determining mechanisms of sensitivity and resistance to HSP90 inhibition in non-small cell lung cancer

Law, E. W. P. (2016) · Figshare

Antitumor Activities of Secondary Metabolites from Marine Microbe Stress Responses to Virus Infection

He, T., Xu, C., & Zhang, X. (2019) · Springer eBooks · doi:10.1007/978-981-13-6198-2_9

Design and synthesis of Hsp90 inhibitors: Exploring the SAR of Sansalvamide A derivatives

Sellers, R. P., Alexander, L. D., Johnson, V. A., Lin, C.-C., Savage, J. H., Corral, R., Moss, J. A., Slugocki, T. S., Singh, E. K., Davis, M. R., et al. (2010) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2010.07.042 · Cited by 82 · see citing works

Design, synthesis, and mechanistic studies of Sansalvamide A derivatives as anti-cancer agents

Alexander, L. D. (2012) · eScholarship (California Digital Library)

Synthesis, characterization, and biological evaluation of Hsp90 inhibitors as anticancer therapeutics

McConnell, J. R. (2022) · UNSWorks (UNSW Sydney) · doi:10.26190/unsworks/18569

Allosteric Regulation of Hsp90α’s Activity by Small Molecules Targeting the Middle Domain of the Chaperone

Zhou, C., Zhang, C., Zhu, H., Liu, Z., Su, H., Zhang, X., Chen, T., Zhong, Y., Hu, H., Xiong, M., et al. (2020) · iScience · doi:10.1016/j.isci.2020.100857 · Cited by 25 · see citing works

Towards allosteric modulators of Hsp90

Sattin, S., Morelli, L., Panza, M., Vettoretti, G., Moroni, E., Colombo, G., & Bernardi, A. (2014)